nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—TOP2A—Mitoxantrone—multiple sclerosis	0.242	0.348	CbGbCtD
Ciprofloxacin—ABCB1—Methylprednisolone—multiple sclerosis	0.0443	0.0638	CbGbCtD
Ciprofloxacin—CYP3A4—Fingolimod—multiple sclerosis	0.0412	0.0593	CbGbCtD
Ciprofloxacin—CYP3A7—Dexamethasone—multiple sclerosis	0.0344	0.0494	CbGbCtD
Ciprofloxacin—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0344	0.0494	CbGbCtD
Ciprofloxacin—ABCB1—Mitoxantrone—multiple sclerosis	0.0324	0.0465	CbGbCtD
Ciprofloxacin—ABCB1—Betamethasone—multiple sclerosis	0.0288	0.0415	CbGbCtD
Ciprofloxacin—ABCB1—Prednisolone—multiple sclerosis	0.0285	0.0409	CbGbCtD
Ciprofloxacin—ABCB1—Prednisone—multiple sclerosis	0.0269	0.0386	CbGbCtD
Ciprofloxacin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0266	0.0382	CbGbCtD
Ciprofloxacin—CYP3A5—Dexamethasone—multiple sclerosis	0.0258	0.0371	CbGbCtD
Ciprofloxacin—CYP3A4—Triamcinolone—multiple sclerosis	0.0201	0.029	CbGbCtD
Ciprofloxacin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0194	0.0279	CbGbCtD
Ciprofloxacin—CYP3A4—Betamethasone—multiple sclerosis	0.0173	0.0248	CbGbCtD
Ciprofloxacin—CYP3A4—Prednisolone—multiple sclerosis	0.017	0.0245	CbGbCtD
Ciprofloxacin—ABCB1—Dexamethasone—multiple sclerosis	0.0168	0.0241	CbGbCtD
Ciprofloxacin—CYP3A4—Prednisone—multiple sclerosis	0.0161	0.0232	CbGbCtD
Ciprofloxacin—ABCB1—Methotrexate—multiple sclerosis	0.0135	0.0194	CbGbCtD
Ciprofloxacin—CYP3A4—Dexamethasone—multiple sclerosis	0.01	0.0145	CbGbCtD
Ciprofloxacin—TOP2A—Floxuridine—Cladribine—multiple sclerosis	0.00144	0.378	CbGdCrCtD
Ciprofloxacin—TOP2A—Clofarabine—Cladribine—multiple sclerosis	0.00101	0.265	CbGdCrCtD
Ciprofloxacin—TOP2A—Azacitidine—Cladribine—multiple sclerosis	0.000614	0.161	CbGdCrCtD
Ciprofloxacin—TOP2A—Methyltestosterone—Prednisone—multiple sclerosis	0.000376	0.0989	CbGdCrCtD
Ciprofloxacin—TOP2A—Methyltestosterone—Prednisolone—multiple sclerosis	0.000367	0.0966	CbGdCrCtD
Ciprofloxacin—Tachycardia—Triamcinolone—multiple sclerosis	0.000112	0.000376	CcSEcCtD
Ciprofloxacin—Mental disorder—Prednisone—multiple sclerosis	0.000112	0.000375	CcSEcCtD
Ciprofloxacin—Nausea—Azathioprine—multiple sclerosis	0.000112	0.000375	CcSEcCtD
Ciprofloxacin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000112	0.000375	CcSEcCtD
Ciprofloxacin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000111	0.000373	CcSEcCtD
Ciprofloxacin—Malnutrition—Prednisone—multiple sclerosis	0.000111	0.000373	CcSEcCtD
Ciprofloxacin—Erythema—Prednisone—multiple sclerosis	0.000111	0.000373	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000111	0.000372	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000111	0.000372	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000111	0.000371	CcSEcCtD
Ciprofloxacin—Convulsion—Dexamethasone—multiple sclerosis	0.00011	0.000371	CcSEcCtD
Ciprofloxacin—Convulsion—Betamethasone—multiple sclerosis	0.00011	0.000371	CcSEcCtD
Ciprofloxacin—Hypertension—Dexamethasone—multiple sclerosis	0.00011	0.000369	CcSEcCtD
Ciprofloxacin—Hypertension—Betamethasone—multiple sclerosis	0.00011	0.000369	CcSEcCtD
Ciprofloxacin—Asthenia—Mitoxantrone—multiple sclerosis	0.000109	0.000366	CcSEcCtD
Ciprofloxacin—Myalgia—Betamethasone—multiple sclerosis	0.000108	0.000364	CcSEcCtD
Ciprofloxacin—Myalgia—Dexamethasone—multiple sclerosis	0.000108	0.000364	CcSEcCtD
Ciprofloxacin—Anxiety—Dexamethasone—multiple sclerosis	0.000108	0.000363	CcSEcCtD
Ciprofloxacin—Anxiety—Betamethasone—multiple sclerosis	0.000108	0.000363	CcSEcCtD
Ciprofloxacin—Discomfort—Betamethasone—multiple sclerosis	0.000107	0.00036	CcSEcCtD
Ciprofloxacin—Discomfort—Dexamethasone—multiple sclerosis	0.000107	0.00036	CcSEcCtD
Ciprofloxacin—Haemoglobin—Methotrexate—multiple sclerosis	0.000107	0.00036	CcSEcCtD
Ciprofloxacin—Hypotension—Methylprednisolone—multiple sclerosis	0.000107	0.000359	CcSEcCtD
Ciprofloxacin—Pain—Prednisolone—multiple sclerosis	0.000107	0.000358	CcSEcCtD
Ciprofloxacin—Hepatitis—Methotrexate—multiple sclerosis	0.000106	0.000358	CcSEcCtD
Ciprofloxacin—Haemorrhage—Methotrexate—multiple sclerosis	0.000106	0.000358	CcSEcCtD
Ciprofloxacin—Pharyngitis—Methotrexate—multiple sclerosis	0.000106	0.000355	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000105	0.000353	CcSEcCtD
Ciprofloxacin—Vision blurred—Prednisone—multiple sclerosis	0.000105	0.000351	CcSEcCtD
Ciprofloxacin—Urethral disorder—Methotrexate—multiple sclerosis	0.000104	0.000351	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000104	0.000351	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000104	0.00035	CcSEcCtD
Ciprofloxacin—Oedema—Betamethasone—multiple sclerosis	0.000104	0.000349	CcSEcCtD
Ciprofloxacin—Oedema—Dexamethasone—multiple sclerosis	0.000104	0.000349	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000104	0.000349	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000104	0.000349	CcSEcCtD
Ciprofloxacin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000104	0.000349	CcSEcCtD
Ciprofloxacin—Insomnia—Triamcinolone—multiple sclerosis	0.000104	0.000348	CcSEcCtD
Ciprofloxacin—Insomnia—Methylprednisolone—multiple sclerosis	0.000103	0.000347	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000103	0.000346	CcSEcCtD
Ciprofloxacin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000103	0.000346	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000103	0.000345	CcSEcCtD
Ciprofloxacin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000103	0.000345	CcSEcCtD
Ciprofloxacin—Visual impairment—Methotrexate—multiple sclerosis	0.000103	0.000345	CcSEcCtD
Ciprofloxacin—Anaemia—Prednisone—multiple sclerosis	0.000103	0.000344	CcSEcCtD
Ciprofloxacin—Shock—Dexamethasone—multiple sclerosis	0.000102	0.000344	CcSEcCtD
Ciprofloxacin—Shock—Betamethasone—multiple sclerosis	0.000102	0.000344	CcSEcCtD
Ciprofloxacin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000102	0.000343	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000102	0.000342	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000102	0.000342	CcSEcCtD
Ciprofloxacin—Agitation—Prednisone—multiple sclerosis	0.000102	0.000342	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000102	0.000342	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000102	0.000342	CcSEcCtD
Ciprofloxacin—Tachycardia—Betamethasone—multiple sclerosis	0.000101	0.000341	CcSEcCtD
Ciprofloxacin—Tachycardia—Dexamethasone—multiple sclerosis	0.000101	0.000341	CcSEcCtD
Ciprofloxacin—Angioedema—Prednisone—multiple sclerosis	0.000101	0.00034	CcSEcCtD
Ciprofloxacin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000101	0.000339	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000101	0.000338	CcSEcCtD
Ciprofloxacin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000101	0.000338	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.0001	0.000338	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.0001	0.000338	CcSEcCtD
Ciprofloxacin—Malaise—Prednisone—multiple sclerosis	0.0001	0.000336	CcSEcCtD
Ciprofloxacin—Vertigo—Prednisone—multiple sclerosis	9.97e-05	0.000335	CcSEcCtD
Ciprofloxacin—Eye disorder—Methotrexate—multiple sclerosis	9.95e-05	0.000334	CcSEcCtD
Ciprofloxacin—Syncope—Prednisone—multiple sclerosis	9.95e-05	0.000334	CcSEcCtD
Ciprofloxacin—Tinnitus—Methotrexate—multiple sclerosis	9.93e-05	0.000334	CcSEcCtD
Ciprofloxacin—Anorexia—Dexamethasone—multiple sclerosis	9.91e-05	0.000333	CcSEcCtD
Ciprofloxacin—Anorexia—Betamethasone—multiple sclerosis	9.91e-05	0.000333	CcSEcCtD
Ciprofloxacin—Urticaria—Prednisolone—multiple sclerosis	9.9e-05	0.000332	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Methotrexate—multiple sclerosis	9.88e-05	0.000332	CcSEcCtD
Ciprofloxacin—Fatigue—Triamcinolone—multiple sclerosis	9.88e-05	0.000332	CcSEcCtD
Ciprofloxacin—Fatigue—Methylprednisolone—multiple sclerosis	9.86e-05	0.000331	CcSEcCtD
Ciprofloxacin—Pain—Triamcinolone—multiple sclerosis	9.8e-05	0.000329	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Prednisone—multiple sclerosis	9.75e-05	0.000327	CcSEcCtD
Ciprofloxacin—Hypotension—Dexamethasone—multiple sclerosis	9.71e-05	0.000326	CcSEcCtD
Ciprofloxacin—Hypotension—Betamethasone—multiple sclerosis	9.71e-05	0.000326	CcSEcCtD
Ciprofloxacin—Angiopathy—Methotrexate—multiple sclerosis	9.66e-05	0.000325	CcSEcCtD
Ciprofloxacin—Vomiting—Mitoxantrone—multiple sclerosis	9.66e-05	0.000324	CcSEcCtD
Ciprofloxacin—Immune system disorder—Methotrexate—multiple sclerosis	9.62e-05	0.000323	CcSEcCtD
Ciprofloxacin—Convulsion—Prednisone—multiple sclerosis	9.61e-05	0.000323	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Methotrexate—multiple sclerosis	9.6e-05	0.000322	CcSEcCtD
Ciprofloxacin—Hypertension—Prednisone—multiple sclerosis	9.58e-05	0.000322	CcSEcCtD
Ciprofloxacin—Rash—Mitoxantrone—multiple sclerosis	9.57e-05	0.000322	CcSEcCtD
Ciprofloxacin—Dermatitis—Mitoxantrone—multiple sclerosis	9.57e-05	0.000321	CcSEcCtD
Ciprofloxacin—Chills—Methotrexate—multiple sclerosis	9.56e-05	0.000321	CcSEcCtD
Ciprofloxacin—Headache—Mitoxantrone—multiple sclerosis	9.51e-05	0.00032	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	9.47e-05	0.000318	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	9.47e-05	0.000318	CcSEcCtD
Ciprofloxacin—Arthralgia—Prednisone—multiple sclerosis	9.44e-05	0.000317	CcSEcCtD
Ciprofloxacin—Myalgia—Prednisone—multiple sclerosis	9.44e-05	0.000317	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Triamcinolone—multiple sclerosis	9.44e-05	0.000317	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Methylprednisolone—multiple sclerosis	9.42e-05	0.000316	CcSEcCtD
Ciprofloxacin—Anxiety—Prednisone—multiple sclerosis	9.41e-05	0.000316	CcSEcCtD
Ciprofloxacin—Alopecia—Methotrexate—multiple sclerosis	9.41e-05	0.000316	CcSEcCtD
Ciprofloxacin—Insomnia—Dexamethasone—multiple sclerosis	9.4e-05	0.000316	CcSEcCtD
Ciprofloxacin—Insomnia—Betamethasone—multiple sclerosis	9.4e-05	0.000316	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	9.38e-05	0.000315	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.35e-05	0.000314	CcSEcCtD
Ciprofloxacin—Paraesthesia—Betamethasone—multiple sclerosis	9.33e-05	0.000314	CcSEcCtD
Ciprofloxacin—Paraesthesia—Dexamethasone—multiple sclerosis	9.33e-05	0.000314	CcSEcCtD
Ciprofloxacin—Discomfort—Prednisone—multiple sclerosis	9.33e-05	0.000313	CcSEcCtD
Ciprofloxacin—Mental disorder—Methotrexate—multiple sclerosis	9.33e-05	0.000313	CcSEcCtD
Ciprofloxacin—Malnutrition—Methotrexate—multiple sclerosis	9.27e-05	0.000311	CcSEcCtD
Ciprofloxacin—Erythema—Methotrexate—multiple sclerosis	9.27e-05	0.000311	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Prednisolone—multiple sclerosis	9.18e-05	0.000308	CcSEcCtD
Ciprofloxacin—Dyspepsia—Dexamethasone—multiple sclerosis	9.15e-05	0.000307	CcSEcCtD
Ciprofloxacin—Dyspepsia—Betamethasone—multiple sclerosis	9.15e-05	0.000307	CcSEcCtD
Ciprofloxacin—Urticaria—Triamcinolone—multiple sclerosis	9.1e-05	0.000306	CcSEcCtD
Ciprofloxacin—Urticaria—Methylprednisolone—multiple sclerosis	9.08e-05	0.000305	CcSEcCtD
Ciprofloxacin—Dysgeusia—Methotrexate—multiple sclerosis	9.08e-05	0.000305	CcSEcCtD
Ciprofloxacin—Body temperature increased—Triamcinolone—multiple sclerosis	9.06e-05	0.000304	CcSEcCtD
Ciprofloxacin—Oedema—Prednisone—multiple sclerosis	9.05e-05	0.000304	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Prednisone—multiple sclerosis	9.05e-05	0.000304	CcSEcCtD
Ciprofloxacin—Abdominal pain—Methylprednisolone—multiple sclerosis	9.04e-05	0.000304	CcSEcCtD
Ciprofloxacin—Decreased appetite—Betamethasone—multiple sclerosis	9.04e-05	0.000304	CcSEcCtD
Ciprofloxacin—Decreased appetite—Dexamethasone—multiple sclerosis	9.04e-05	0.000304	CcSEcCtD
Ciprofloxacin—Nausea—Mitoxantrone—multiple sclerosis	9.02e-05	0.000303	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	8.97e-05	0.000301	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	8.97e-05	0.000301	CcSEcCtD
Ciprofloxacin—Back pain—Methotrexate—multiple sclerosis	8.97e-05	0.000301	CcSEcCtD
Ciprofloxacin—Fatigue—Betamethasone—multiple sclerosis	8.96e-05	0.000301	CcSEcCtD
Ciprofloxacin—Fatigue—Dexamethasone—multiple sclerosis	8.96e-05	0.000301	CcSEcCtD
Ciprofloxacin—Shock—Prednisone—multiple sclerosis	8.91e-05	0.000299	CcSEcCtD
Ciprofloxacin—Pain—Dexamethasone—multiple sclerosis	8.89e-05	0.000299	CcSEcCtD
Ciprofloxacin—Pain—Betamethasone—multiple sclerosis	8.89e-05	0.000299	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Prednisone—multiple sclerosis	8.88e-05	0.000298	CcSEcCtD
Ciprofloxacin—Tachycardia—Prednisone—multiple sclerosis	8.84e-05	0.000297	CcSEcCtD
Ciprofloxacin—Skin disorder—Prednisone—multiple sclerosis	8.79e-05	0.000295	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Prednisone—multiple sclerosis	8.75e-05	0.000294	CcSEcCtD
Ciprofloxacin—Vision blurred—Methotrexate—multiple sclerosis	8.74e-05	0.000293	CcSEcCtD
Ciprofloxacin—Anorexia—Prednisone—multiple sclerosis	8.63e-05	0.00029	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Methotrexate—multiple sclerosis	8.6e-05	0.000289	CcSEcCtD
Ciprofloxacin—Anaemia—Methotrexate—multiple sclerosis	8.57e-05	0.000288	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Betamethasone—multiple sclerosis	8.57e-05	0.000288	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Dexamethasone—multiple sclerosis	8.57e-05	0.000288	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	8.5e-05	0.000286	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Betamethasone—multiple sclerosis	8.5e-05	0.000286	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Triamcinolone—multiple sclerosis	8.44e-05	0.000284	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.42e-05	0.000283	CcSEcCtD
Ciprofloxacin—Malaise—Methotrexate—multiple sclerosis	8.36e-05	0.000281	CcSEcCtD
Ciprofloxacin—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	8.33e-05	0.0254	CbGpPWpGaD
Ciprofloxacin—Vertigo—Methotrexate—multiple sclerosis	8.33e-05	0.00028	CcSEcCtD
Ciprofloxacin—Leukopenia—Methotrexate—multiple sclerosis	8.3e-05	0.000279	CcSEcCtD
Ciprofloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	8.27e-05	0.0252	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	8.27e-05	0.0252	CbGpPWpGaD
Ciprofloxacin—Urticaria—Dexamethasone—multiple sclerosis	8.26e-05	0.000277	CcSEcCtD
Ciprofloxacin—Urticaria—Betamethasone—multiple sclerosis	8.26e-05	0.000277	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.25e-05	0.000277	CcSEcCtD
Ciprofloxacin—Dizziness—Prednisolone—multiple sclerosis	8.24e-05	0.000277	CcSEcCtD
Ciprofloxacin—Asthenia—Triamcinolone—multiple sclerosis	8.22e-05	0.000276	CcSEcCtD
Ciprofloxacin—Abdominal pain—Betamethasone—multiple sclerosis	8.22e-05	0.000276	CcSEcCtD
Ciprofloxacin—Abdominal pain—Dexamethasone—multiple sclerosis	8.22e-05	0.000276	CcSEcCtD
Ciprofloxacin—Body temperature increased—Dexamethasone—multiple sclerosis	8.22e-05	0.000276	CcSEcCtD
Ciprofloxacin—Body temperature increased—Betamethasone—multiple sclerosis	8.22e-05	0.000276	CcSEcCtD
Ciprofloxacin—Asthenia—Methylprednisolone—multiple sclerosis	8.2e-05	0.000276	CcSEcCtD
Ciprofloxacin—Insomnia—Prednisone—multiple sclerosis	8.19e-05	0.000275	CcSEcCtD
Ciprofloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	8.16e-05	0.0249	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	8.16e-05	0.0249	CbGpPWpGaD
Ciprofloxacin—Paraesthesia—Prednisone—multiple sclerosis	8.13e-05	0.000273	CcSEcCtD
Ciprofloxacin—Pruritus—Triamcinolone—multiple sclerosis	8.11e-05	0.000272	CcSEcCtD
Ciprofloxacin—Cough—Methotrexate—multiple sclerosis	8.09e-05	0.000272	CcSEcCtD
Ciprofloxacin—Pruritus—Methylprednisolone—multiple sclerosis	8.09e-05	0.000272	CcSEcCtD
Ciprofloxacin—Convulsion—Methotrexate—multiple sclerosis	8.03e-05	0.00027	CcSEcCtD
Ciprofloxacin—Dyspepsia—Prednisone—multiple sclerosis	7.97e-05	0.000268	CcSEcCtD
Ciprofloxacin—Chest pain—Methotrexate—multiple sclerosis	7.89e-05	0.000265	CcSEcCtD
Ciprofloxacin—Myalgia—Methotrexate—multiple sclerosis	7.89e-05	0.000265	CcSEcCtD
Ciprofloxacin—Arthralgia—Methotrexate—multiple sclerosis	7.89e-05	0.000265	CcSEcCtD
Ciprofloxacin—Decreased appetite—Prednisone—multiple sclerosis	7.87e-05	0.000264	CcSEcCtD
Ciprofloxacin—Rash—Prednisolone—multiple sclerosis	7.86e-05	0.000264	CcSEcCtD
Ciprofloxacin—Dermatitis—Prednisolone—multiple sclerosis	7.85e-05	0.000264	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	7.84e-05	0.000263	CcSEcCtD
Ciprofloxacin—Diarrhoea—Methylprednisolone—multiple sclerosis	7.82e-05	0.000263	CcSEcCtD
Ciprofloxacin—Fatigue—Prednisone—multiple sclerosis	7.81e-05	0.000262	CcSEcCtD
Ciprofloxacin—Headache—Prednisolone—multiple sclerosis	7.8e-05	0.000262	CcSEcCtD
Ciprofloxacin—Discomfort—Methotrexate—multiple sclerosis	7.8e-05	0.000262	CcSEcCtD
Ciprofloxacin—Constipation—Prednisone—multiple sclerosis	7.74e-05	0.00026	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	7.71e-05	0.0235	CbGpPWpGaD
Ciprofloxacin—Confusional state—Methotrexate—multiple sclerosis	7.63e-05	0.000256	CcSEcCtD
Ciprofloxacin—Dizziness—Triamcinolone—multiple sclerosis	7.58e-05	0.000254	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Methotrexate—multiple sclerosis	7.57e-05	0.000254	CcSEcCtD
Ciprofloxacin—Dizziness—Methylprednisolone—multiple sclerosis	7.56e-05	0.000254	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Prednisone—multiple sclerosis	7.46e-05	0.000251	CcSEcCtD
Ciprofloxacin—Asthenia—Dexamethasone—multiple sclerosis	7.46e-05	0.000251	CcSEcCtD
Ciprofloxacin—Asthenia—Betamethasone—multiple sclerosis	7.46e-05	0.000251	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Methotrexate—multiple sclerosis	7.42e-05	0.000249	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Methotrexate—multiple sclerosis	7.41e-05	0.000249	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Prednisone—multiple sclerosis	7.4e-05	0.000249	CcSEcCtD
Ciprofloxacin—Nausea—Prednisolone—multiple sclerosis	7.4e-05	0.000249	CcSEcCtD
Ciprofloxacin—Pruritus—Dexamethasone—multiple sclerosis	7.35e-05	0.000247	CcSEcCtD
Ciprofloxacin—Pruritus—Betamethasone—multiple sclerosis	7.35e-05	0.000247	CcSEcCtD
Ciprofloxacin—Skin disorder—Methotrexate—multiple sclerosis	7.35e-05	0.000247	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Methotrexate—multiple sclerosis	7.31e-05	0.000246	CcSEcCtD
Ciprofloxacin—Vomiting—Triamcinolone—multiple sclerosis	7.28e-05	0.000245	CcSEcCtD
Ciprofloxacin—Vomiting—Methylprednisolone—multiple sclerosis	7.27e-05	0.000244	CcSEcCtD
Ciprofloxacin—Rash—Triamcinolone—multiple sclerosis	7.22e-05	0.000243	CcSEcCtD
Ciprofloxacin—Dermatitis—Triamcinolone—multiple sclerosis	7.22e-05	0.000242	CcSEcCtD
Ciprofloxacin—Anorexia—Methotrexate—multiple sclerosis	7.21e-05	0.000242	CcSEcCtD
Ciprofloxacin—Rash—Methylprednisolone—multiple sclerosis	7.21e-05	0.000242	CcSEcCtD
Ciprofloxacin—Dermatitis—Methylprednisolone—multiple sclerosis	7.2e-05	0.000242	CcSEcCtD
Ciprofloxacin—Urticaria—Prednisone—multiple sclerosis	7.19e-05	0.000242	CcSEcCtD
Ciprofloxacin—Headache—Triamcinolone—multiple sclerosis	7.18e-05	0.000241	CcSEcCtD
Ciprofloxacin—Headache—Methylprednisolone—multiple sclerosis	7.16e-05	0.000241	CcSEcCtD
Ciprofloxacin—Abdominal pain—Prednisone—multiple sclerosis	7.16e-05	0.00024	CcSEcCtD
Ciprofloxacin—Body temperature increased—Prednisone—multiple sclerosis	7.16e-05	0.00024	CcSEcCtD
Ciprofloxacin—Diarrhoea—Dexamethasone—multiple sclerosis	7.11e-05	0.000239	CcSEcCtD
Ciprofloxacin—Diarrhoea—Betamethasone—multiple sclerosis	7.11e-05	0.000239	CcSEcCtD
Ciprofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	7.1e-05	0.0217	CbGpPWpGaD
Ciprofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	7.1e-05	0.0217	CbGpPWpGaD
Ciprofloxacin—Hypotension—Methotrexate—multiple sclerosis	7.07e-05	0.000237	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	6.89e-05	0.000232	CcSEcCtD
Ciprofloxacin—Dizziness—Dexamethasone—multiple sclerosis	6.87e-05	0.000231	CcSEcCtD
Ciprofloxacin—Dizziness—Betamethasone—multiple sclerosis	6.87e-05	0.000231	CcSEcCtD
Ciprofloxacin—Insomnia—Methotrexate—multiple sclerosis	6.84e-05	0.00023	CcSEcCtD
Ciprofloxacin—Nausea—Triamcinolone—multiple sclerosis	6.81e-05	0.000229	CcSEcCtD
Ciprofloxacin—Paraesthesia—Methotrexate—multiple sclerosis	6.79e-05	0.000228	CcSEcCtD
Ciprofloxacin—Nausea—Methylprednisolone—multiple sclerosis	6.79e-05	0.000228	CcSEcCtD
Ciprofloxacin—Dyspnoea—Methotrexate—multiple sclerosis	6.75e-05	0.000227	CcSEcCtD
Ciprofloxacin—Somnolence—Methotrexate—multiple sclerosis	6.73e-05	0.000226	CcSEcCtD
Ciprofloxacin—CYP3A7—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	6.7e-05	0.0205	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	6.7e-05	0.0205	CbGpPWpGaD
Ciprofloxacin—Hypersensitivity—Prednisone—multiple sclerosis	6.67e-05	0.000224	CcSEcCtD
Ciprofloxacin—Dyspepsia—Methotrexate—multiple sclerosis	6.66e-05	0.000224	CcSEcCtD
Ciprofloxacin—Vomiting—Betamethasone—multiple sclerosis	6.61e-05	0.000222	CcSEcCtD
Ciprofloxacin—Vomiting—Dexamethasone—multiple sclerosis	6.61e-05	0.000222	CcSEcCtD
Ciprofloxacin—Decreased appetite—Methotrexate—multiple sclerosis	6.58e-05	0.000221	CcSEcCtD
Ciprofloxacin—Rash—Dexamethasone—multiple sclerosis	6.55e-05	0.00022	CcSEcCtD
Ciprofloxacin—Rash—Betamethasone—multiple sclerosis	6.55e-05	0.00022	CcSEcCtD
Ciprofloxacin—Dermatitis—Betamethasone—multiple sclerosis	6.55e-05	0.00022	CcSEcCtD
Ciprofloxacin—Dermatitis—Dexamethasone—multiple sclerosis	6.55e-05	0.00022	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.53e-05	0.000219	CcSEcCtD
Ciprofloxacin—Fatigue—Methotrexate—multiple sclerosis	6.52e-05	0.000219	CcSEcCtD
Ciprofloxacin—Headache—Dexamethasone—multiple sclerosis	6.51e-05	0.000219	CcSEcCtD
Ciprofloxacin—Headache—Betamethasone—multiple sclerosis	6.51e-05	0.000219	CcSEcCtD
Ciprofloxacin—Asthenia—Prednisone—multiple sclerosis	6.5e-05	0.000218	CcSEcCtD
Ciprofloxacin—Pain—Methotrexate—multiple sclerosis	6.47e-05	0.000217	CcSEcCtD
Ciprofloxacin—Pruritus—Prednisone—multiple sclerosis	6.41e-05	0.000215	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Methotrexate—multiple sclerosis	6.23e-05	0.000209	CcSEcCtD
Ciprofloxacin—Diarrhoea—Prednisone—multiple sclerosis	6.19e-05	0.000208	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.19e-05	0.000208	CcSEcCtD
Ciprofloxacin—Nausea—Dexamethasone—multiple sclerosis	6.17e-05	0.000207	CcSEcCtD
Ciprofloxacin—Nausea—Betamethasone—multiple sclerosis	6.17e-05	0.000207	CcSEcCtD
Ciprofloxacin—Urticaria—Methotrexate—multiple sclerosis	6.01e-05	0.000202	CcSEcCtD
Ciprofloxacin—Dizziness—Prednisone—multiple sclerosis	5.99e-05	0.000201	CcSEcCtD
Ciprofloxacin—Abdominal pain—Methotrexate—multiple sclerosis	5.98e-05	0.000201	CcSEcCtD
Ciprofloxacin—Body temperature increased—Methotrexate—multiple sclerosis	5.98e-05	0.000201	CcSEcCtD
Ciprofloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	5.98e-05	0.0182	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	5.98e-05	0.0182	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	5.9e-05	0.018	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	5.9e-05	0.018	CbGpPWpGaD
Ciprofloxacin—Vomiting—Prednisone—multiple sclerosis	5.76e-05	0.000193	CcSEcCtD
Ciprofloxacin—Rash—Prednisone—multiple sclerosis	5.71e-05	0.000192	CcSEcCtD
Ciprofloxacin—Dermatitis—Prednisone—multiple sclerosis	5.7e-05	0.000192	CcSEcCtD
Ciprofloxacin—Headache—Prednisone—multiple sclerosis	5.67e-05	0.000191	CcSEcCtD
Ciprofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	5.67e-05	0.0173	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	5.67e-05	0.0173	CbGpPWpGaD
Ciprofloxacin—Hypersensitivity—Methotrexate—multiple sclerosis	5.57e-05	0.000187	CcSEcCtD
Ciprofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—multiple sclerosis	5.45e-05	0.0166	CbGpPWpGaD
Ciprofloxacin—Asthenia—Methotrexate—multiple sclerosis	5.43e-05	0.000182	CcSEcCtD
Ciprofloxacin—Nausea—Prednisone—multiple sclerosis	5.38e-05	0.000181	CcSEcCtD
Ciprofloxacin—Pruritus—Methotrexate—multiple sclerosis	5.35e-05	0.00018	CcSEcCtD
Ciprofloxacin—Diarrhoea—Methotrexate—multiple sclerosis	5.18e-05	0.000174	CcSEcCtD
Ciprofloxacin—Dizziness—Methotrexate—multiple sclerosis	5e-05	0.000168	CcSEcCtD
Ciprofloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	4.84e-05	0.0148	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	4.84e-05	0.0148	CbGpPWpGaD
Ciprofloxacin—Vomiting—Methotrexate—multiple sclerosis	4.81e-05	0.000162	CcSEcCtD
Ciprofloxacin—Rash—Methotrexate—multiple sclerosis	4.77e-05	0.00016	CcSEcCtD
Ciprofloxacin—Dermatitis—Methotrexate—multiple sclerosis	4.77e-05	0.00016	CcSEcCtD
Ciprofloxacin—Headache—Methotrexate—multiple sclerosis	4.74e-05	0.000159	CcSEcCtD
Ciprofloxacin—Nausea—Methotrexate—multiple sclerosis	4.49e-05	0.000151	CcSEcCtD
Ciprofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	4.38e-05	0.0134	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	4.38e-05	0.0134	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	4.11e-05	0.0125	CbGpPWpGaD
Ciprofloxacin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	4.05e-05	0.0123	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	3.87e-05	0.0118	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	3.6e-05	0.011	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	3.6e-05	0.011	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	3.56e-05	0.0109	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	3.56e-05	0.0109	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	3.55e-05	0.0108	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	3.55e-05	0.0108	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.51e-05	0.0107	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.51e-05	0.0107	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	3.09e-05	0.00942	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—C4A—multiple sclerosis	3.08e-05	0.00939	CbGpPWpGaD
Ciprofloxacin—TOP2A—Gastric Cancer Network 2—MYC—multiple sclerosis	3.02e-05	0.00922	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	2.92e-05	0.00891	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	2.92e-05	0.00891	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	2.78e-05	0.00848	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	2.78e-05	0.00848	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	2.74e-05	0.00837	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	2.74e-05	0.00837	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	2.57e-05	0.00785	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	2.57e-05	0.00785	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.54e-05	0.00774	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.54e-05	0.00774	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	2.51e-05	0.00765	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	2.51e-05	0.00765	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	2.49e-05	0.00761	CbGpPWpGaD
Ciprofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	2.32e-05	0.00709	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	2.28e-05	0.00696	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	2.25e-05	0.00687	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	2.25e-05	0.00687	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.25e-05	0.00687	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	2.15e-05	0.00657	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	1.95e-05	0.00596	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	1.94e-05	0.00591	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.86e-05	0.00567	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.86e-05	0.00566	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.81e-05	0.00552	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	1.71e-05	0.00523	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	1.69e-05	0.00517	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	1.69e-05	0.00515	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CD28—multiple sclerosis	1.65e-05	0.00502	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	1.58e-05	0.00481	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	1.56e-05	0.00477	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	1.55e-05	0.00473	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	1.55e-05	0.00473	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.55e-05	0.00472	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.53e-05	0.00467	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.53e-05	0.00467	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.51e-05	0.0046	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CD40—multiple sclerosis	1.5e-05	0.00459	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—FAS—multiple sclerosis	1.49e-05	0.00453	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	1.48e-05	0.00452	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.43e-05	0.00437	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	1.35e-05	0.00413	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.34e-05	0.0041	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	1.32e-05	0.00404	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	1.3e-05	0.00398	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	1.22e-05	0.00372	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.2e-05	0.00365	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.2e-05	0.00365	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.18e-05	0.0036	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.18e-05	0.0036	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CD86—multiple sclerosis	1.17e-05	0.00358	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	1.15e-05	0.00351	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IL10—multiple sclerosis	1.15e-05	0.00351	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IL4—multiple sclerosis	1.12e-05	0.00342	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	1.1e-05	0.00334	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.09e-05	0.00333	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—FAS—multiple sclerosis	1.03e-05	0.00315	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	1.03e-05	0.00313	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	1.01e-05	0.0031	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—multiple sclerosis	9.31e-06	0.00284	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	9.27e-06	0.00283	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—SRM—multiple sclerosis	8.64e-06	0.00264	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	8.57e-06	0.00261	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	8.33e-06	0.00254	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.1e-06	0.00247	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Biological oxidations—POMC—multiple sclerosis	8.01e-06	0.00244	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.63e-06	0.00233	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	7.43e-06	0.00227	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.41e-06	0.00226	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	7.4e-06	0.00226	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.05e-06	0.00215	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.03e-06	0.00215	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.9e-06	0.00211	CbGpPWpGaD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.89e-06	0.0021	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	6.77e-06	0.00207	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.57e-06	0.002	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.56e-06	0.002	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.25e-06	0.00191	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—SRM—multiple sclerosis	6.25e-06	0.00191	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	6.09e-06	0.00186	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	6.09e-06	0.00186	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	6.04e-06	0.00184	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	6.02e-06	0.00184	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.95e-06	0.00182	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.95e-06	0.00182	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.95e-06	0.00182	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.79e-06	0.00177	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—POMC—multiple sclerosis	5.79e-06	0.00177	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.78e-06	0.00176	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.78e-06	0.00176	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.66e-06	0.00173	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GPC5—multiple sclerosis	5.57e-06	0.0017	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.39e-06	0.00165	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.39e-06	0.00165	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.09e-06	0.00155	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—IL6—multiple sclerosis	5.09e-06	0.00155	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.07e-06	0.00155	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—SRM—multiple sclerosis	4.71e-06	0.00144	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.69e-06	0.00143	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—RRM1—multiple sclerosis	4.61e-06	0.00141	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.57e-06	0.00139	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.4e-06	0.00134	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.4e-06	0.00134	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.38e-06	0.00134	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.04e-06	0.00123	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.02e-06	0.00123	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—SRM—multiple sclerosis	3.76e-06	0.00115	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.49e-06	0.00106	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—multiple sclerosis	3.41e-06	0.00104	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	3.34e-06	0.00102	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.34e-06	0.00102	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.32e-06	0.00101	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.32e-06	0.00101	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MYC—multiple sclerosis	3.05e-06	0.000931	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GPC5—multiple sclerosis	3.04e-06	0.000927	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MAPK1—multiple sclerosis	2.99e-06	0.000911	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—SRM—multiple sclerosis	2.9e-06	0.000886	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.69e-06	0.000821	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.65e-06	0.000809	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.65e-06	0.000809	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.65e-06	0.000809	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.59e-06	0.000791	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—RRM1—multiple sclerosis	2.52e-06	0.000768	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.42e-06	0.00074	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.32e-06	0.000709	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.32e-06	0.000707	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.27e-06	0.000693	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.16e-06	0.00066	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.05e-06	0.000624	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.05e-06	0.000624	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.01e-06	0.000613	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.92e-06	0.000585	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.87e-06	0.000571	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—APOE—multiple sclerosis	1.59e-06	0.000486	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.56e-06	0.000476	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.55e-06	0.000473	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.45e-06	0.000444	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—BCHE—multiple sclerosis	1.45e-06	0.000441	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—POMC—multiple sclerosis	1.37e-06	0.000418	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.34e-06	0.000409	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—ALB—multiple sclerosis	1.25e-06	0.000381	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.22e-06	0.000373	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.15e-06	0.000352	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—APOE—multiple sclerosis	1.15e-06	0.000352	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—POMC—multiple sclerosis	9.9e-07	0.000302	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—ALB—multiple sclerosis	9.03e-07	0.000275	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.91e-07	0.000272	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—APOE—multiple sclerosis	8.7e-07	0.000265	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—POMC—multiple sclerosis	7.47e-07	0.000228	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—APOE—multiple sclerosis	6.94e-07	0.000212	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—ALB—multiple sclerosis	6.81e-07	0.000208	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—POMC—multiple sclerosis	5.96e-07	0.000182	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—ALB—multiple sclerosis	5.44e-07	0.000166	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—APOE—multiple sclerosis	5.36e-07	0.000163	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—POMC—multiple sclerosis	4.6e-07	0.00014	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—ALB—multiple sclerosis	4.2e-07	0.000128	CbGpPWpGaD
